Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1245.50
-24.30 (-1.91%)
< Home < Back

Dr. Reddy’s, Promius Pharma file NDA for migraine candidate with USFDA

Date: 03-04-2018

Dr. Reddy’s Laboratories and its US subsidiary Promius Pharma LLC have filed New Drug Application (NDA) for its migraine candidate DFN-02 with the US Food and Drug Administration (USFDA).

The filing of DFN-02 NDA represents the company’s continuing commitment to bring innovative solutions in migraine treatment.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.